Scpharmaceuticals Drug Patent Portfolio

Scpharmaceuticals owns 1 orange book drug protected by 4 US patents Given below is the list of Scpharmaceuticals's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10272064 Pharmaceutical formulations for subcutaneous administration of furosemide 03 Apr, 2034
Active
US11433044 Pharmaceutical formulations for subcutaneous administration of furosemide 03 Apr, 2034
Active
US12370168 Pharmaceutical Formulations For Subcutaneous Administration Of Furosemide 03 Apr, 2034
Active
US9884039 Pharmaceutical formulations for subcutaneous administration of furosemide 03 Apr, 2034
Active


Given below is the list of recent legal activities going on the following drug patents of Scpharmaceuticals.

Activity Date Patent Number
Patent litigations
Recordation of Patent Grant Mailed 05 Aug, 2025 US12370168
Mail Patent eGrant Notification 29 Jul, 2025 US12370168
Recordation of Patent eGrant 29 Jul, 2025 US12370168
Patent eGrant Notification 29 Jul, 2025 US12370168
Patent Issue Date Used in PTA Calculation 29 Jul, 2025 US12370168
Email Notification 29 Jul, 2025 US12370168
Email Notification 17 Jul, 2025 US12370168
Issue Notification Mailed 16 Jul, 2025 US12370168
Payment of Maintenance Fee, 8th Yr, Small Entity 15 Jul, 2025 US9884039
Application Is Considered Ready for Issue 26 Jun, 2025 US12370168
Dispatch to FDC 26 Jun, 2025 US12370168
Issue Fee Payment Verified 25 Jun, 2025 US12370168
Issue Fee Payment Received 25 Jun, 2025 US12370168
Mail Notice of Allowance 26 Mar, 2025 US12370168
Notice of Allowance Data Verification Completed 23 Mar, 2025 US12370168


Scpharmaceuticals's Family Patents

Scpharmaceuticals drugs have patent protection in a total of 15 countries. It's US patent count contributes only to 25.0% of its total global patent coverage. Click below to unlock the full patent family tree.

Family Patents



Scpharmaceuticals Drug List

Given below is the complete list of Scpharmaceuticals's drugs and the patents protecting them.


1. Furoscix

Furoscix is protected by 4 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10272064 Pharmaceutical formulations for subcutaneous administration of furosemide 03 Apr, 2034
(8 years from now)
Active
US11433044 Pharmaceutical formulations for subcutaneous administration of furosemide 03 Apr, 2034
(8 years from now)
Active
US12370168 Pharmaceutical Formulations For Subcutaneous Administration Of Furosemide 03 Apr, 2034
(8 years from now)
Active
US9884039 Pharmaceutical formulations for subcutaneous administration of furosemide 03 Apr, 2034
(8 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Furoscix's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List